Similar to our findings, another preclinical model of CCL4-induced liver fibrosis found that nintedanib significantly attenuated collagen accumulation and hepatic stellate cell activation, inhibiting intrahepatic inflammation and angiogenesis [15]. The gene discussed is CCL4; the disease is Hepatic fibrosis.